From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (WKN: A41AYF) (the "Company"...
Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for...
The field hockey star uses the sam® sustained acoustic medicine device from ZetrOZ Systems to manage knee osteoarthritis, keep playing...
A new report from the Franklin & Marshall's Center for Opinion Research and the Initiative for Medicines, Access & Knowledge...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
Management to Showcase Full Nature-Cide Product Line at Industry's Flagship Event LOS ANGELES, CA / ACCESS Newswire / October 20,...
NAPLES, FL / ACCESS Newswire / October 20, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell...
Five-year strategy positions the iconic Lifeline brand to reach one million older adults through a connected healthcare ecosystem debuting at...
FORT LAUDERDALE, FL / ACCESS Newswire / October 20, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Compiled by Black Book Research from VC PE and banking investors, the briefing ranks which AI-driven categories are converting pilots...
Polaris AI leverages Google Cloud’s Gemini family of multimodal models and Eleos’ secure and clinically validated infrastructure to reduce documentation...
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA...
TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will...
Survey will assess demographics, salary rates, moreArlington, Virginia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Soon, the health technology community will...
MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and...
Read about Crazybulk SARMs Rad 140 (Testolone) Rad 140 Benefits and Side Effects, What Is Rad 140, Rad 140 Cycle,...
Detailed results from bezuclastinib’s positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis planned for presentation at upcoming...
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One®...
New life sciences executive brings more than 25 years of legal expertise spanning clinical and commercial stage biopharmaceutical companiesSEATTLE and...
